Jazz Pharmaceuticals plc, a biopharmaceutical company based in Dublin, Ireland, is making waves in the field of pharmaceutical products for unmet medical needs. With a focus on neuroscience and oncology, the company has a portfolio of products and product candidates that offer promising solutions for patients suffering from different ailments. In the neuroscience field, Jazz Pharmaceuticals' lead marketed products include Xywav, Xyrem, and Epidiolex which offer hope for the treatment of sleep disorders and seizures associated with various syndromes. Meanwhile, in oncology, the company's lead marketed products include Zepzelca, Rylaze, Vyxeos, and Defitelio which offer solutions for the treatment of small cell lung cancer, leukemia, and acute myeloid leukemia, among others. Jazz Pharmaceuticals' partnerships with various companies including Sumitomo Pharma, Ligand Pharmaceuticals, and Zymeworks, among others, speak to its commitment to collaboration in developing new and innovative solutions for unmet medical needs.
Jazz Pharmaceuticals's ticker is JAZZ
The company's shares trade on the NASDAQ stock exchange
They are based in Dublin, Ireland
There are 501-1000 employees working at Jazz Pharmaceuticals
It is jazzpharma.com
Jazz Pharmaceuticals is in the Healthcare sector
Jazz Pharmaceuticals is in the Biotechnology industry
The following five companies are Jazz Pharmaceuticals's industry peers: